WindMIL Therapeutics, a clinical-stage company developing marrow-infiltrating lymphocytes (MILs®) for cancer immunotherapy, today announced the appointment of Co-Founder Kimberly Noonan, PhD, MPH, to Executive Vice President, Chief Science & Technology Officer. In this role, Dr. Noonan’s leadership will expand to include WindMIL’s efforts in manufacturing and manufacturing science and technology (MS&T).Read more
People On The Move
Every career has milestones. Please share in the celebration of these individuals as they take on new challenges and work toward future successes.
Celebrate Your Team. Celebrate Their Success.
Take a Minute to Learn More About the Most Recent POTM
Submit your People on the Move
Share your pride for a new hire, promotion, or career accomplishment. Keeps your team front and center and create buzz around your company as a great place to work.Submit Today